adjuvant therapy for resected stage iii melanoma
Published 3 years ago • 43 plays • Length 3:37Download video MP4
Download video MP3
Similar videos
-
7:39
adjuvant nivolumab versus ipilimumab for resected stage iii/iv melanoma
-
5:59
optimizing the approach to adjuvant therapy for resected melanoma
-
55:30
preferences for adjuvant immunotherapy in resected stage iii melanoma
-
10:47
asco: pembrolizumab for adjuvant treatment of high-risk stage iii melanoma
-
5:00
adjuvant therapy for stage iii melanoma
-
6:22
response-driven surgery and adjuvant therapy after neoadjuvant immunotherapy for stage iii melanoma
-
3:13
recurrence of patients on adjuvant therapy with stage iii melanoma
-
5:30
jeffrey s weber, asco 2018 – resected stage iii melanoma and the checkmate 238 trial
-
1:30
adjuvant therapy for high-risk melanoma
-
21:16
adjuvant and neoadjuvant therapy for stage ii and iii melanoma
-
6:31
case consult: adjuvant therapy following localized treatment for stage iii melanoma
-
2:05
dr. weber on adjuvant approaches in stage iii melanoma
-
2:06
dr. tarhini discusses adjuvant therapy for melanoma
-
5:29
benefits and risks of treatment with ipilimumab after complete resection of stage iii melanoma
-
6:25
combination targeted adjuvant therapy doubles relapse-free survival in stage iii melanoma
-
13:35
adjuvant options for stage iii melanoma
-
5:22
adjuvant therapy in stage 3 and 4 melanoma - 2022 program: melanoma video library
-
2:46
neoadjuvant therapy in bulky stage iii melanoma
-
1:18
comment: ipilimumab in high risk stage iii melanoma